logo

Equity Analysis

Company Profile
Detailed Quotes

Company Snapshot

    Sandu Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524703
    INE751D01014
    42.2883059
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    27.93
    50.72
    EPS(TTM)
    Face Value()
    Div & Yield %:
    1.88
    10
    1.52
     


As on: Mar 13, 2025 11:03 AM
Last Price() Net Change (%) Volume (Nos) P / E
52.50 0.00 1811 27.93
Chart
  • |
  • |
  • |
  • |
Stock Price Details
Open Price() 54.00
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 54.98
Today's Low () 51.00
52-Week High () 69.5
152-Week Low () 47
Market Statistics
Div & Yield % 1.52
Eps 1.88
Book Value 42.2883059
Market Cap (.Cr) 50.72
Face Value 10
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE751D01014


News
Sandu Pharmaceuticals Ltd - Announcement Under Reg 30-Update-Clarification To Your Email Dated 18.02.2025 On Non-Compliance With Regulation 33 Of SEBI (LODR) Regulations 2015 For The Period Ended December 31 2024.
Sandu Pharmaceuticals standalone net profit rises 166.67% in the December 2024 quarter
Sandu Pharmaceuticals Ltd - Announcement Under Reg 30 Of SEBI (LODR)-Update-Intimation Inrespect Of The Order Received From Government Of Maharashtra Department Of Goods And Service Tax
Sandu Pharmaceuticals to convene board meeting
Sandu Pharmaceuticals Ltd - Announcement Under Regulation 30 Order To Drop Proceeding In Respect Of Return After Scrutiny For The Financial Year 2020-2021 Under Section 61 Of CGST Act .
Sandu Pharmaceuticals Ltd - Corrigendum To The Unaudited Financial Results Of The Company For The Period Ended On September 30 2024.
Sandu Pharmaceuticals Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sandu Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sandu Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sandu Pharmaceuticals standalone net profit declines 9.09% in the September 2024 quarter
More
Corporate Details
Incoporation Year   : 1985
Chairman : Balaram Vishwanathan
Bussiness Group :
Registered Office
Sandu Pharmaceuticals Ltd
Plot No 25/26/29 & 30,
Pilerne Indl Estate Marra Bard,
Bardez,
Goa-403511
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:N.A.
Fax:N.A.
Fax:91-22-66317458
E-Mail : corp.sec@sandu.in
URL : http://www.sandu.in